Cargando…
A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1
BACKGROUND: Glucagon-like peptide-1 (GLP-1) (7–36) is a peptide incretin hormone released from the endocrine L-cells of the intestinal mucosa with unique antidiabetic potential. Due to low absorption efficiency and instability in the gastrointestinal tract, the introduction of orally active GLP-1 is...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446861/ https://www.ncbi.nlm.nih.gov/pubmed/23028226 http://dx.doi.org/10.2147/IJN.S30013 |
_version_ | 1782244026605371392 |
---|---|
author | Qu, Wei Li, Yong Hovgaard, Lars Li, Song Dai, Wenbin Wang, Jiancheng Zhang, Xuan Zhang, Qiang |
author_facet | Qu, Wei Li, Yong Hovgaard, Lars Li, Song Dai, Wenbin Wang, Jiancheng Zhang, Xuan Zhang, Qiang |
author_sort | Qu, Wei |
collection | PubMed |
description | BACKGROUND: Glucagon-like peptide-1 (GLP-1) (7–36) is a peptide incretin hormone released from the endocrine L-cells of the intestinal mucosa with unique antidiabetic potential. Due to low absorption efficiency and instability in the gastrointestinal tract, the introduction of orally active GLP-1 is a large challenge. Here we developed a novel silica-based pH-sensitive nanomatrix of GLP-1 (SPN-GLP-1) in order to provide a strategy for oral peptide delivery. METHODS: SPN-GLP-1 composed of silica nanoparticles and pH-sensitive Eudragit(®) was prepared and characterized by dynamic light scattering, scanning electron microscope, transmission electron microscope, high-performance liquid chromatography, surface analysis, drug release, and so on. Its permeability across the Caco-2 cell monolayer and intestinal mucosa, proteolytic stability against the intestinal enzymes, pharmacokinetics, hypoglycemic effect in the intraperitoneal glucose tolerance test (IPGTT), and primary toxicity were then evaluated. RESULTS: It was indicated that the nanomatrix system obtained had a unique nanoscale structure and pH-sensitivity in drug release. It displayed a five-fold intestinal mucosa permeability and significantly higher proteolytic stability compared to native GLP-1 (P < 0.001). A longer half-life was observed after oral administration of SPN-GLP-1, and its relative bioavailability was 35.67% in comparison to intraperitoneal GLP-1. Oral delivery of SPN-GLP-1 significantly reduced the blood glucose level and its hypoglycemic effect over intraperitoneal GLP-1 reached 77%. There was no evident toxicity of SPN-GLP-1 found from both animal status and histochemical analysis of gastrointestinal tissues. CONCLUSION: The silica-based pH-sensitive nanomatrix designed and prepared here might be considered as a potential oral delivery system not only for GLP-1, but also for other peptide or macromolecular drugs. |
format | Online Article Text |
id | pubmed-3446861 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-34468612012-10-01 A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1 Qu, Wei Li, Yong Hovgaard, Lars Li, Song Dai, Wenbin Wang, Jiancheng Zhang, Xuan Zhang, Qiang Int J Nanomedicine Original Research BACKGROUND: Glucagon-like peptide-1 (GLP-1) (7–36) is a peptide incretin hormone released from the endocrine L-cells of the intestinal mucosa with unique antidiabetic potential. Due to low absorption efficiency and instability in the gastrointestinal tract, the introduction of orally active GLP-1 is a large challenge. Here we developed a novel silica-based pH-sensitive nanomatrix of GLP-1 (SPN-GLP-1) in order to provide a strategy for oral peptide delivery. METHODS: SPN-GLP-1 composed of silica nanoparticles and pH-sensitive Eudragit(®) was prepared and characterized by dynamic light scattering, scanning electron microscope, transmission electron microscope, high-performance liquid chromatography, surface analysis, drug release, and so on. Its permeability across the Caco-2 cell monolayer and intestinal mucosa, proteolytic stability against the intestinal enzymes, pharmacokinetics, hypoglycemic effect in the intraperitoneal glucose tolerance test (IPGTT), and primary toxicity were then evaluated. RESULTS: It was indicated that the nanomatrix system obtained had a unique nanoscale structure and pH-sensitivity in drug release. It displayed a five-fold intestinal mucosa permeability and significantly higher proteolytic stability compared to native GLP-1 (P < 0.001). A longer half-life was observed after oral administration of SPN-GLP-1, and its relative bioavailability was 35.67% in comparison to intraperitoneal GLP-1. Oral delivery of SPN-GLP-1 significantly reduced the blood glucose level and its hypoglycemic effect over intraperitoneal GLP-1 reached 77%. There was no evident toxicity of SPN-GLP-1 found from both animal status and histochemical analysis of gastrointestinal tissues. CONCLUSION: The silica-based pH-sensitive nanomatrix designed and prepared here might be considered as a potential oral delivery system not only for GLP-1, but also for other peptide or macromolecular drugs. Dove Medical Press 2012 2012-09-14 /pmc/articles/PMC3446861/ /pubmed/23028226 http://dx.doi.org/10.2147/IJN.S30013 Text en © 2012 Qu et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Qu, Wei Li, Yong Hovgaard, Lars Li, Song Dai, Wenbin Wang, Jiancheng Zhang, Xuan Zhang, Qiang A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1 |
title | A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1 |
title_full | A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1 |
title_fullStr | A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1 |
title_full_unstemmed | A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1 |
title_short | A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1 |
title_sort | silica-based ph-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1 |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446861/ https://www.ncbi.nlm.nih.gov/pubmed/23028226 http://dx.doi.org/10.2147/IJN.S30013 |
work_keys_str_mv | AT quwei asilicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1 AT liyong asilicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1 AT hovgaardlars asilicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1 AT lisong asilicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1 AT daiwenbin asilicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1 AT wangjiancheng asilicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1 AT zhangxuan asilicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1 AT zhangqiang asilicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1 AT quwei silicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1 AT liyong silicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1 AT hovgaardlars silicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1 AT lisong silicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1 AT daiwenbin silicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1 AT wangjiancheng silicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1 AT zhangxuan silicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1 AT zhangqiang silicabasedphsensitivenanomatrixsystemimprovestheoralabsorptionandefficacyofincretinhormoneglucagonlikepeptide1 |